Prostate cancer may be deadlier for the uninsured
(HealthDay)—Men who are uninsured or underinsured get advanced prostate cancer at nearly four times the national average and don't survive as long as other men with advanced disease, a new study says.
Cancer
May 07, 2013 |
5 / 5 (1) |
0
Using genetic variants to improve PSA testing technique and reduce biopsies
With the help of genetics, prostate specific antigen (PSA) screenings may become more accurate and reduce the number of unnecessary prostate biopsies, according to a new study from Northwestern Medicine.
Cancer
Apr 24, 2013 |
5 / 5 (1) |
0
Nearly half of all deaths from prostate cancer can be predicted before age 50
Focusing prostate cancer testing on men at highest risk of developing the disease is likely to improve the ratio between benefits and the harms of screening, suggests a paper published today in BMJ.
Cancer
Apr 16, 2013 |
5 / 5 (2) |
0
Personalizing prostate specific antigen testing may improve specificity, reduce biopsies
Genetic variants have been identified which can increase serum prostate specific antigen (PSA) concentrations and prostate cancer risk. A new study published in The Journal of Urology reports that correcting PSA levels for th ...
Cancer
Apr 15, 2013 |
not rated yet |
0
Focal therapy offers middle ground for some prostate cancer patients
Men with low-risk prostate cancer who previously had to choose between aggressive treatment, with the potential for significant side effects, and active surveillance, with the risk of disease progression, may have a new option. ...
Cancer
Mar 05, 2013 |
not rated yet |
0
First study ever to analyze 25 years of data after radiation therapy for prostate cancer patients
The March 2013 issue of The Journal of Urology, the official journal of The American Urological Association, includes a study conducted by four physicians from Radiotherapy Clinics of Georgia (RCOG), a Vantage Oncology affili ...
Cancer
Feb 27, 2013 |
not rated yet |
0
Virus shows promise as prostate cancer treatment
A recombinant Newcastle disease virus kills all kinds of prostate cancer cells, including hormone resistant cells, but leaves normal cells unscathed, according to a paper published online ahead of print in the Journal of ...
Cancer
Feb 25, 2013 |
5 / 5 (3) |
0
|
New genetic test can predict man's risk of developing prostate cancer
Researchers in Japan have created a genetic test that will help doctors diagnose prostate cancer. When given together with testing for prostate specific antigen (PSA), a widely used diagnostic biomarker for ...
Cancer
Feb 08, 2013 |
5 / 5 (3) |
0
|
Prostate cancer lifetime risk trebles in 25 years
Boys born in 2015 will have almost three times the risk of being diagnosed with prostate cancer at some point during their lives than those born in 1990.
Cancer
Jan 23, 2013 |
not rated yet |
0
Follow-up to REDUCE study shows low rate of prostate cancer diagnosis
The four-year REDUCE (REduction by DUtasteride of prostate Cancer Events) clinical study evaluated prostate cancer risk reduction in men taking dutasteride, a 5-alpha-reductase inhibitor (5ARI) typically used to treat enlarged ...
Cancer
Jan 22, 2013 |
not rated yet |
0
Change in PSA levels over time can help predict aggressive prostate cancer
Measurements taken over time of prostate specific antigen, the most commonly used screening test for prostate cancer in men, improve the accuracy of aggressive prostate cancer detection when compared to a single measurement ...
Cancer
Jan 15, 2013 |
not rated yet |
0
Updated 'Partin Tables' tool now available to predict prostate cancer spread
Prostate cancer experts at Johns Hopkins have developed an updated version of the Partin Tables, a tool to help men diagnosed with prostate cancer and their doctors to better assess their chance of a surgical cure. The updated ...
Cancer
Jan 04, 2013 |
not rated yet |
0
Game changing diagnostic and prognostic prostate cancer genetic tests revealed
Researchers at the Kimmel Cancer Center at Jefferson (KCC) have developed potentially game-changing diagnostic and prognostic genetic tests shown to better predict prostate cancer survival outcomes and distinguish clinically-relevant ...
Cancer
Dec 20, 2012 |
not rated yet |
0
Cancer study overturns current thinking about gene activation
(Medical Xpress)—A new Australian study led by Professor Susan Clark from Sydney's Garvan Institute of Medical Research shows that large regions of the genome – amounting to roughly 2% – are epigenetically activated ...
Cancer
Dec 18, 2012 |
5 / 5 (1) |
0
|
Abiraterone benefits chemo-naive with advanced prostate CA
(HealthDay)—For chemotherapy-naive patients with metastatic castration-resistant prostate cancer, abiraterone acetate correlates with improved radiographic progression-free survival, according to a study ...
Cancer
Dec 12, 2012 |
not rated yet |
0
